Pharmaceutical industry bodies in the UK and the EU have called on the UK government and the European Commission to prioritize medicines in their negotiations on a trade deal, saying that companies are still “working in the dark” in critical areas of drug regulation, supply and safety reporting.
This week sees the start of the last scheduled round of trade talks, but issues such as fishing rights and UK rules on state aid are still proving major obstacles...